with us
together we’re making a difference

News Releases

Sep 23, 2021 |

Annexon Biosciences to Participate in 2021 Cantor Virtual Global Healthcare Conference

Sep 20, 2021 |

Annexon Biosciences to Highlight Neurodegeneration Franchise in Upcoming Virtual C1q Series R&D Event

Aug 16, 2021 |

Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update

Jul 22, 2021 |

Annexon Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candidate and Strategic Expansion into New Autoantibody-driven Diseases

Jun 16, 2021 |

Annexon to Present at the Raymond James Human Health Innovation Conference

May 17, 2021 |

Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results

May 05, 2021 |

Annexon to Present at the BofA Securities 2021 Virtual Healthcare Conference

Mar 25, 2021 |

Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights

Mar 01, 2021 |

Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy

Feb 08, 2021 |

Annexon Welcomes William H. Carson, M.D. to the Board of Directors
Displaying 1 - 10 of 12
Print
IR Contact
RSS Feeds
Email Alerts
Contact Us

info@annexonbio.com
650.822.5500

Annexon Biosciences

180 Kimball Way,
2nd Floor, Suite 200
South San Francisco, CA 94080

© 2021 Annexon Inc. All rights reserved.